These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 22421945)

  • 1. Agonistic antibody to CD40 boosts the antitumor activity of adoptively transferred T cells in vivo.
    Liu C; Lewis CM; Lou Y; Xu C; Peng W; Yang Y; Gelbard AH; Lizée G; Zhou D; Overwijk WW; Hwu P
    J Immunother; 2012 Apr; 35(3):276-82. PubMed ID: 22421945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Critical Role of CD40 and CD70 Signaling in Conventional Type 1 Dendritic Cells in Expansion and Antitumor Efficacy of Adoptively Transferred Tumor-Specific T Cells.
    Oba T; Hoki T; Yamauchi T; Keler T; Marsh HC; Cao X; Ito F
    J Immunol; 2020 Oct; 205(7):1867-1877. PubMed ID: 32848036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells strongly boost the antitumor activity of adoptively transferred T cells in vivo.
    Lou Y; Wang G; Lizée G; Kim GJ; Finkelstein SE; Feng C; Restifo NP; Hwu P
    Cancer Res; 2004 Sep; 64(18):6783-90. PubMed ID: 15374997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD40 ligation activates murine macrophages via an IFN-gamma-dependent mechanism resulting in tumor cell destruction in vitro.
    Buhtoiarov IN; Lum H; Berke G; Paulnock DM; Sondel PM; Rakhmilevich AL
    J Immunol; 2005 May; 174(10):6013-22. PubMed ID: 15879094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival.
    Lu L; Li W; Fu F; Chambers FG; Qian S; Fung JJ; Thomson AW
    Transplantation; 1997 Dec; 64(12):1808-15. PubMed ID: 9422424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific antitumor activity of tumor-infiltrating lymphocytes expanded first in a culture with both anti-CD3 monoclonal antibody and activated B cells and then in a culture with interleukin-2.
    Tamada K; Harada M; Okamoto T; Takenoyama M; Ito O; Matsuzaki G; Nomoto K
    Cancer Immunol Immunother; 1995 Dec; 41(6):339-47. PubMed ID: 8635191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD28, TNF receptor, and IL-12 are critical for CD4-independent cross-priming of therapeutic antitumor CD8+ T cells.
    Hu HM; Winter H; Ma J; Croft M; Urba WJ; Fox BA
    J Immunol; 2002 Nov; 169(9):4897-904. PubMed ID: 12391201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo CD40 ligation can induce T-cell-independent antitumor effects that involve macrophages.
    Lum HD; Buhtoiarov IN; Schmidt BE; Berke G; Paulnock DM; Sondel PM; Rakhmilevich AL
    J Leukoc Biol; 2006 Jun; 79(6):1181-92. PubMed ID: 16565324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced T-cell-independent antitumor effect of cyclophosphamide combined with anti-CD40 mAb and CpG in mice.
    Johnson EE; Buhtoiarov IN; Baldeshwiler MJ; Felder MA; Van Rooijen N; Sondel PM; Rakhmilevich AL
    J Immunother; 2011 Jan; 34(1):76-84. PubMed ID: 21150715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production.
    Van Gool SW; Vermeiren J; Rafiq K; Lorr K; de Boer M; Ceuppens JL
    Eur J Immunol; 1999 Aug; 29(8):2367-75. PubMed ID: 10458748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD86 (B7-2) on human B cells. A functional role in proliferation and selective differentiation into IgE- and IgG4-producing cells.
    Jeannin P; Delneste Y; Lecoanet-Henchoz S; Gauchat JF; Ellis J; Bonnefoy JY
    J Biol Chem; 1997 Jun; 272(25):15613-9. PubMed ID: 9188449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-1 enhances T cell-dependent antibody production through induction of CD40 ligand and OX40 on T cells.
    Nakae S; Asano M; Horai R; Sakaguchi N; Iwakura Y
    J Immunol; 2001 Jul; 167(1):90-7. PubMed ID: 11418636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine Fibroblastic Reticular Cells From Lymph Node Interact With CD4+ T Cells Through CD40-CD40L.
    Nakayama Y; Brinkman CC; Bromberg JS
    Transplantation; 2015 Aug; 99(8):1561-7. PubMed ID: 25856408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways.
    Hayakawa Y; Takeda K; Yagita H; Van Kaer L; Saiki I; Okumura K
    J Immunol; 2001 May; 166(10):6012-8. PubMed ID: 11342617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving Efficacy and Safety of Agonistic Anti-CD40 Antibody Through Extracellular Matrix Affinity.
    Ishihara J; Ishihara A; Potin L; Hosseinchi P; Fukunaga K; Damo M; Gajewski TF; Swartz MA; Hubbell JA
    Mol Cancer Ther; 2018 Nov; 17(11):2399-2411. PubMed ID: 30097487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling through CD40 enhances cytotoxic T lymphocyte generation by CD8+ T cells from mice bearing large tumors.
    Donepudi M; Quach DD; Mokyr MB
    Cancer Immunol Immunother; 1999; 48(2-3):153-64. PubMed ID: 10414470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective Combination of Innate and Adaptive Immunotherapeutic Approaches in a Mouse Melanoma Model.
    Rakhmilevich AL; Felder M; Lever L; Slowinski J; Rasmussen K; Hoefges A; Van De Voort TJ; Loibner H; Korman AJ; Gillies SD; Sondel PM
    J Immunol; 2017 Feb; 198(4):1575-1584. PubMed ID: 28062694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of CD86 and CD40 induces alloantigen-specific immunoregulatory T cells that remain anergic even after reversal of hyporesponsiveness.
    Koenen HJ; Joosten I
    Blood; 2000 May; 95(10):3153-61. PubMed ID: 10807782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of costimulatory molecule CD40 in murine heart with acute myocarditis and reduction of inflammation by treatment with anti-CD40L/B7-1 monoclonal antibodies.
    Seko Y; Takahashi N; Azuma M; Yagita H; Okumura K; Yazaki Y
    Circ Res; 1998 Aug; 83(4):463-9. PubMed ID: 9721703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid induction of a novel costimulatory activity on B cells by CD40 ligand.
    Wu Y; Xu J; Shinde S; Grewal I; Henderson T; Flavell RA; Liu Y
    Curr Biol; 1995 Nov; 5(11):1303-11. PubMed ID: 8574588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.